Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2025-12-26 @ 11:11 AM
NCT ID:
NCT05101928
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Diagnosis of non-infectious intermediate, posterior, or panuveitis in at least one eye
* Active uveitic disease at Screening/Baseline defined by the presence of at least 1 of the following parameters: 1) Active, inflammatory, chorioretinal and/or inflammatory retinal vascular lesion 2) ≥ 1+ vitreous haze (NEI/SUN criteria)
Exclusion Criteria:
* Presence of isolated anterior uveitis
* Evidence of macular edema due to diabetes, retinal vein occlusion or any other ocular conditions
* Confirmed or suspected active ocular disease or infections
* Intraocular surgery in the past 6 months
* History of glaucoma
* Intraocular pressure (IOP) of \>21 mmHg at Screening/Baseline or confirmed normal-tension glaucoma
* Intravitreal or periocular injection within 6 months prior to screening.
* Unable to tolerate systemic corticosteroids
* Prior topical corticosteroid within 1 month of screening
* Prior non-steroidal anti-inflammatory, systemic steroids, or immunomodulatory therapy (e.g. methotrexate) within 1 month of screening
* For women: pregnant or breast feeding, or planning to become pregnant while enrolled in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05101928
Study Brief:
Protocol Section:
NCT05101928